FDA Inspection
IQVIA BiotechIQVIA Biotech – FDA Inspection, Jan 27, 2025
Record Details
This FDA Inspection record concerns IQVIA Biotech, with an inspection on January 27, 2025, issued by the Atlanta District Office, covering human drugs.
- Office
- Atlanta District Office
- Person
- Nigel L. Hirth (Issuing Officer)
View Company Profile
ID · 99dc63eb-74a1-4a42-b5e1-055144af48d5
Inspection Facts
- Inspection number
- 1259905
- FDA center
- Human Drugs
Other FDA inspections of IQVIA Biotech
3| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| April 27, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 13, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for IQVIA Biotech
- FDA Inspection 1224954 - 2023-12-07
- FDA Inspection 1204132 - 2023-04-27
- FDA Inspection 1147013 - 2021-07-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.